Collegium pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Collegium Pharmaceutical Inc: Is Infosys Ltd. worth buying?
Item: Collegium Pharmaceutical Inc
Rating: 2.187805625
Author: Trendlyne DVM scores

Mid-range Performer

about

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated pr...

34.50 -0.50 (-1.43%)

32.07% Fall from 52W High

413.5K

XNAS Volume

XNAS 13 Mar, 2026 4:11 PM (EDT)

Medium Financial Strength

38.9 / 100

Affordable Valuation

53.2 / 100

Technically Neutral

44.1 / 100

Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM

1Yr Price target upside is 56%

6 analysts

Collegium pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Collegium pharma Inc Live Stock Price Today, Share Analysis and Chart

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated pr...

32.07% Fall from 52W High

SWOT Analysis

Collegium pharma Inc Live Price Chart